Pagaya Technologies (NASDAQ:PGY) stands to gain from Walmart's (WMT) shift to Klarna (KLAR) as its new exclusive provider of ...

Equities research analysts at B. Riley dropped their Q2 2025 earnings per share (EPS) estimates for Trevi Therapeutics in a ...

B. Riley increased their Q2 2025 earnings per share (EPS) estimates for RF Industries in a report released on Tuesday, March ...

B. Riley sees mixed Q4 results but gains aftermarket interest. Despite mild improvements, my long-term view on RILY stock is negative. Read an analysis here.

Fintel reports that on March 19, 2025, B. Riley Securities downgraded their outlook for Quanta Services (NYSE:PWR) from Buy ...

B. Riley Financial, Inc.’s RILY share price has dipped by 10.10%, which has investors questioning if this is right time to buy.

B. Riley initiated coverage of ArriVent Biopharma (AVBP) with a Buy rating and $37 price target The firm sees potential market expansion of ...

B. Riley Financial Inc. missed the deadline for filing its annual report for a third year in a row, delaying its to return to a normal schedule as the firm deals with the aftermath of soured ...

B. Riley Securities, the investment banking group, has merged with Cascadia Investments Inc., a shell entity. As a result, ...

B. Riley analyst Nick Giles initiated coverage of United States Antimony (UAMY) with a Buy rating and $3 price target U.S. Antimony could more ...

Shares of B. Riley Financial were recently down 2.7%, to $4.34. The stock has fallen about 6% this year and 78% over the past 52 weeks.